This report uses market-leading social listening techniques and analytics to uncover the experiences,
frustrations and needs of Alzheimer’s patients and carers.
With increasing focus on disease modifying treatments in the Alzheimer’s space,
multiple touchpoints are highlighted where pharma can support and enhance the treatment
management process
for all stakeholders.
A series of five reports that brings the MS patient voice directly to pharma. Conducted over two years, Ipsos’ MS Patient Community offered unique visibility of patients’ unmet needs via an ongoing online panel of those living with the condition. Interactive activities focused on specific elements of the MS patient journey, offering insights to support a patient-centric strategy.